Drug Trial Radar · NCT07071623
A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)
Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,580
Planned (sponsor's estimate)
Start
Nov 10, 2025
Primary completion
Oct 18, 2027
Study completion Oct 18, 2027
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Jul 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 16 years, up to 30 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HIV-1 infection better than a standard (usual) pre-exposure prophylaxis (PrEP) taken once a day * About the safety of MK-8527 and if people tolerate it
Conditions
- Human Immunodeficiency Virus (HIV)
- HIV Pre-Exposure Prophylaxis
Interventions
MK-8527Drug
Oral tablet
Emtricitabine/tenofovir disoproxil (FTC/TDF)Drug
Oral tablet
Placebo matched to MK-8527Drug
Placebo oral tablet matched to MK-8527
Placebo matched to FTC/TDFDrug
Placebo oral tablet matched to FTC/TDF
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Adjudicated Human Immunodeficiency Virus Type 1 (HIV-1) InfectionTime frame: Up to ~2 years
- Number of Participants who Experience At Least One Adverse Event (AE)Time frame: Up to ~2 years
- Number of Participants who Discontinue Study Intervention Due to an AETime frame: Up to ~2 years
Locations
30 sites in 3 countries. Site status is shown where the registry gives one.
Kargeno Research & Policy Hub ( Site 0007)
Kisumu, Kenya · Recruiting
UW - KNH; Rachuonyo County Hospital ( Site 0006)
Homabay County, Homa Bay County, Kenya · Recruiting
Partners in Health and Research Development (PHRD) ( Site 0002)
Thika, Kiambu County, Kenya · Active not recruiting
KEMRI-CMR-RCTP ( Site 0003)
Nairobi, Kisumu County, Kenya · Recruiting
Synergy Biomed Research Institute ( Site 0040)
East London, Eastern Cape, South Africa · Recruiting
Foundation For Professional Development ( Site 0031)
Ndevana, Eastern Cape, South Africa · Active not recruiting
Josha Research ( Site 0045)
Bloemfontein, Free State, South Africa · Active not recruiting
Wits RHI Ward 21 Clinical Research site ( Site 0022)
Johannesburg, Gauteng, South Africa · Recruiting
Helen Joseph Hospital-Clinical HIV Research Unit ( Site 0048)
Johannesburg, Gauteng, South Africa · Active not recruiting
Perinatal HIV Research Unit (PHRU) ( Site 0033)
Johnnesburg, Gauteng, South Africa · Recruiting
Setshaba Research Centre ( Site 0032)
Pretoria, Gauteng, South Africa · Recruiting
SA Medical Research Council - Chatsworth Clinical Research Site ( Site 0026)
Chatsworth, KwaZulu-Natal, South Africa · Active not recruiting
SA Medical Research Council - Botha's Hill Clinical Research Site ( Site 0035)
Durban, KwaZulu-Natal, South Africa · Active not recruiting
CAPRISA eThekwini Clinical Research Site ( Site 0030)
Durban, KwaZulu-Natal, South Africa · Active not recruiting
Wits Maternal Adolescent and Child Health Research Unit (WMRU) ( Site 0027)
Durban, KwaZulu-Natal, South Africa · Recruiting
Umlazi Clinical Research Site ( Site 0047)
Durban, KwaZulu-Natal, South Africa · Recruiting
SYNAPSE Research Clinic ( Site 0043)
Edendale, KwaZulu-Natal, South Africa · Recruiting
Qhakaza Mbokodo Research Clinic ( Site 0028)
Ladysmith, KwaZulu-Natal, South Africa · Recruiting
SA Medical Research Council - Phoenix Clinical Research Site ( Site 0037)
Phoenix, KwaZulu-Natal, South Africa · Recruiting
CAPRISA Vulindlela Clinical Research Site ( Site 0029)
Pietermaritzburg, KwaZulu-Natal, South Africa · Recruiting
Africa Health Research Institute (AHRI) - Mtubatuba ( Site 0049)
Somkhele - Mtubatuba, KwaZulu-Natal, South Africa · Active not recruiting
SA Medical Research Council - Verulam Clinical Research Site ( Site 0036)
Verulam, KwaZulu-Natal, South Africa · Recruiting
Desmond Tutu Health Foundation. Philippi Village ( Site 0024)
Cape Town, Western Cape, South Africa · Recruiting
DTHF Masiphumelele Clinical Research Site ( Site 0023)
Cape Town, Western Cape, South Africa · Recruiting
Vuka Research Clinic ( Site 0025)
Khayelitsha, Western Cape, South Africa · Active not recruiting
MU-JHU Research Collaboration - Kampala ( Site 0062)
Kampala, Uganda · Recruiting
MRC/UVRI and LSHTM Uganda Research Unit Masaka ( Site 0064)
Entebbe, Central Region, Uganda · Recruiting
Infectious Diseases Institute Kalangala ( Site 0063)
Kalangala District, Kalangala, Uganda · Recruiting
MU-JHU Research Collaboration - Mityana ( Site 0061)
Mityana, District, Mityana, Uganda · Recruiting
UVRI Clinical Research Program Initiative Ltd (UVRI CRP) ( Site 0067)
Entebbe, Wakiso, Uganda · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.